CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

被引：0
作者：
Christian Daniel Fankhauser
Lisa Roth
Nico Christian Grossmann
Benedikt Kranzbühler
Daniel Eberli
Tullio Sulser
Holger Moch
Peter-Karl Bode
Joerg Beyer
Thomas Hermanns
机构：
[1] University Hospital,Department of Urology
[2] University of Zurich,Department of Pathology of Molecular Pathology
[3] University Hospital,Department of Oncology
[4] University of Zurich,undefined
[5] University Hospital,undefined
[6] University of Bern,undefined
来源：
BMC Cancer | / 19卷
关键词：
Testicular germ cell tumor; Biomarkers, tumor; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 27 条
  • [1] CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors
    Fankhauser, Christian Daniel
    Roth, Lisa
    Grossmann, Nico Christian
    Kranzbuehler, Benedikt
    Eberli, Daniel
    Sulser, Tullio
    Moch, Holger
    Bode, Peter-Karl
    Beyer, Joerg
    Hermanns, Thomas
    BMC CANCER, 2019, 19 (01)
  • [2] Differential Akt Signalling in Non-seminomatous Testicular Germ Cell Tumors
    Hennenlotter, Joerg
    Amend, Bastian
    Vogel, Ulrich
    Renninger, Markus
    Springer, Christine
    Kuehs, Ursula
    Stenzl, Arnulf
    Bedke, Jens
    ANTICANCER RESEARCH, 2011, 31 (11) : 3783 - 3788
  • [3] Paraneoplastic Hyperthyroidism in Advanced Testicular Non-Seminomatous Germ Cell Tumors: Prevalence and Clinical Management
    Angerer, Markus
    Hansen, Bendix
    Wuelfing, Christian
    Dieckmann, Klaus-Peter
    ONCOLOGY, 2024, 102 (11) : 988 - 995
  • [4] Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumors
    Miyai, Kosuke
    Iwaya, Keiichi
    Asano, Tomohiko
    Tamai, Seiichi
    Matsubara, Osamu
    Tsuda, Hitoshi
    VIRCHOWS ARCHIV, 2014, 464 (02) : 221 - 228
  • [5] Bone marrow metastasis in a patient with non-seminomatous testicular germ cell tumor
    Ueda, Takashi
    Takada, Ippei
    Shimizu, Teruki
    Ito, Saya
    Fujihara, Atsuko
    Shiraishi, Takumi
    Nakamura, Terukazu
    Ukimura, Osamu
    IJU CASE REPORTS, 2022, 5 (04) : 247 - 250
  • [6] Is a risk-adapted therapy possible in clinical stage I non-seminomatous testicular germ cell tumors?
    Heidenreich, A
    Neubauer, S
    Moul, JW
    AKTUELLE UROLOGIE, 1998, 29 (03) : 93 - 102
  • [7] Positron emission tomography (PET) is not indicated in the postchemotherapy evaluation of advanced non-seminomatous testicular germ cell tumors
    J. Aparicio
    Clinical and Translational Oncology, 2014, 16 : 509 - 510
  • [8] Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors
    Massard, C.
    Kramar, A.
    Beyer, J.
    Hartmann, J. T.
    Lorch, A.
    Pico, J. L.
    Rosti, G.
    Droz, J. P.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2013, 24 (02) : 322 - 328
  • [9] Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors
    Terbuch, Angelika
    Posch, Florian
    Bauernhofer, Thomas
    Pichler, Martin
    Peinsith, Heidi
    Szkandera, Joanna
    Riedl, Jakob
    Hutterer, Georg C.
    Pummer, Karl
    Partl, Richard
    Kapp, Karin S.
    Stoeger, Herbert
    Stotz, Michael
    Gerger, Armin
    ANTICANCER RESEARCH, 2019, 39 (10) : 5589 - 5596
  • [10] Bone Metastases in Non-Seminomatous Germ Cell Tumors: A 20-Year Retrospective Analysis
    Gille, Romane
    Allignet, Benoit
    Izarn, Floriane
    Peyrat, Patrice
    Boyle, Helen
    Flechon, Aude
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
123